Skip to main content
EMC Instytut Medyczny S.A. logo

EMC Instytut Medyczny S.A. — Investor Relations & Filings

Ticker · EMC ISIN · PLEMCIM00017 LEI · 2594005WSYZ0JRE8U796 WAR Human health and social work activities
Open in API
Filings indexed 786 across all filing types
Latest filing 2020-11-04 Major Shareholding Noti…
Country PL Poland
Listing WAR EMC

About EMC Instytut Medyczny S.A.

https://www.emc-sa.pl/en

EMC Instytut Medyczny S.A. is a significant operator of private hospitals and outpatient clinics. The company provides comprehensive healthcare services through a network of medical facilities. Its operations are structured into three primary segments: Hospital Care, Outpatient Care, and Clinical Trials. The company offers a wide range of medical specializations, including dermatology, gastroenterology, and immunology. In addition to its core patient care services, EMC Instytut Medyczny is also actively engaged in conducting clinical research.

Recent filings

Filing Released Lang Actions
Trzecie wezwanie akcjonariuszy do złożenia w Spółce akcji niezdematerializowanych w związku z obowiązkiem dematerializacji akcji - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document is written in Polish and concerns the mandatory dematerialization of company shares (replacing paper certificates with electronic entries in a shareholder register) as required by a specific Polish law amendment from August 30, 2019. It is a formal notice from the Management Board (Zarząd Spółki) calling upon shareholders to submit their paper share documents before a deadline (March 1, 2021). This type of official notification regarding changes in share structure, legal requirements affecting ownership, or mandatory corporate actions, which doesn't fit neatly into standard financial reports (10-K, IR, ER), is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the focus was on the capital structure change itself. Given the nature of the announcement—a legal mandate affecting share documentation and rights—RNS (Regulatory Filings) serves as the most appropriate general category for miscellaneous, legally driven corporate announcements that aren't standard disclosures like dividends or insider trades. The document length is short (1594 chars), but it is the primary announcement, not an announcement *of* another report, so RPA is not applicable.
2020-11-04 Polish
Informacja o pozwie o uchylenie lub stwierdzenie nieważności uchwał Walnego Zgromadzenia EMC Instytut Medyczny S.A. - Content (PL)
Legal Proceedings Report Classification · 99% confidence The document text, written in Polish, discusses a lawsuit filed against the company ('powództwa') concerning the annulment or invalidation of resolutions passed during the General Meeting ('uchwał Walnego Zgromadzenia'). Specifically, it mentions a court order to suspend the execution of a resolution related to depriving shareholders of pre-emptive rights for Series K shares and suspending the registration proceedings for a capital increase. This content directly relates to significant legal proceedings involving the company and its shareholder resolutions. Based on the definitions, the most appropriate category is Legal Proceedings Report (LTR). It is not an AGM presentation (AGM-R), a general voting result (DVA), or a management change (MANG).
2020-10-30 Polish
Przygotowania do procesu likwidacji Szpitala św. Jerzego w Kamieniu Pomorskim - Content (PL)
Legal Proceedings Report Classification · 99% confidence The document text is a formal communication (Raportem nr 25/2019, Raportem nr 5/2020) detailing ongoing negotiations regarding the potential sale or liquidation of a hospital asset (Szpital św. Jerzego w Kamieniu Pomorskim). It discusses the status of these negotiations, the potential for liquidation, and references Article 17(1) of MAR (Market Abuse Regulation), which mandates the immediate disclosure of inside information. This content relates to significant corporate actions, specifically concerning the disposal or closure of a major operational unit, which often falls under material events requiring disclosure. Since it is a specific report detailing a significant corporate event (asset disposal/liquidation planning) and not merely an announcement of a standard periodic report (like 10-K or IR), it best fits the category for significant corporate events or legal/material updates. Given the context of asset disposal/liquidation planning, it is most closely related to a major corporate transaction or legal/material event. It is not a standard financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It is a specific disclosure of a material event concerning the company's operations and assets. This type of specific, material, non-standard disclosure often defaults to Regulatory Filings (RNS) if a more specific category like M&A (TAR) doesn't perfectly apply, or Legal Proceedings (LTR) if it were a lawsuit. Since it concerns the potential closure/sale of a business unit, which is a major corporate event, and is mandated by MAR, RNS is the most appropriate general regulatory disclosure category for material, non-standard news.
2020-10-28 Polish
Objęcie udziałów w podwyższonym kapitale zakładowym spółki Zdrowie Sp. z o.o. - Content (PL)
Capital/Financing Update Classification · 98% confidence The document text, written in Polish, describes a transaction where EMC Instytut Medyczny S.A. subscribed to new shares (udziałów) in a subsidiary (Zdrowie Sp. z o.o.) as part of a capital increase (podwyższeniem kapitału zakładowego) in exchange for a monetary contribution (wkład pieniężny). This action directly relates to changes in the company's capital structure and financing activities. This aligns best with the 'Capital/Financing Update' category (CAP). The reference to MAR (Market Abuse Regulation) suggests a mandatory disclosure related to significant corporate actions.
2020-10-26 Polish
Drugie wezwanie akcjonariuszy do złożenia w Spółce akcji niezdematerializowanych w związku z obowiązkiem dematerializacji akcji - Content (PL)
Regulatory Filings Classification · 99% confidence The document is written in Polish and concerns the mandatory dematerialization of company shares (replacing paper certificates with electronic entries in a shareholder register) as required by a specific Polish law amendment from August 30, 2019. It is a formal notice from the Management Board (Zarząd Spółki) calling upon shareholders to submit their paper share documents before a deadline (March 1, 2021). This type of official notification regarding changes in share structure, legal requirements affecting ownership, or mandatory corporate actions, which doesn't fit neatly into standard financial reports (10-K, IR, ER), is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the focus was on the capital structure change itself. Given the nature of the announcement—a legal mandate affecting share documentation and rights—RNS (Regulatory Filings) serves as the most appropriate general category for miscellaneous, legally driven corporate announcements that aren't standard disclosures like dividends or insider trades. The document length is short (1594 chars), but it is the primary announcement, not an announcement *of* another report, so RPA is not applicable.
2020-10-14 Polish
Opinia Rady Nadzorczej do Stanowiska Zarządu
Management Reports Classification · 99% confidence The document is a resolution (UCHWAŁA NR 3/09/2020) from the Supervisory Board (Rada Nadzorcza) of EMC Instytut Medyczny SA, dated September 25, 2020. The core purpose of this resolution is to positively opine on the Management Board's position regarding the 'raport z przeglądu śródrocznego sprawozdania finansowego' (report on the review of the interim financial statement) for the period 01.01.2020 to 30.06.2020. This explicitly concerns an interim/half-year financial report. Since the document itself is the Supervisory Board's opinion/approval of the interim report, and not the comprehensive interim report itself, it is best classified as a regulatory or governance document related to financial reporting. Given the specific nature of the content (Supervisory Board opinion on an interim report review) and the reference to Polish financial regulations, it is a specific regulatory announcement. While it relates to an Interim Report (IR), the document is the formal resolution approving the review, making it a specific type of regulatory filing. However, since the content is entirely focused on the review and approval of the 'interim financial statement' (śródroczne sprawozdanie finansowe), the most relevant category describing the subject matter is Interim Report (IR). If a more specific governance code existed for Board Opinions, that would be used, but among the provided codes, IR captures the subject matter best, or RNS as a general regulatory filing. Given the context of financial reporting review, IR is slightly more descriptive than the general RNS fallback, although it is not the report itself. Considering the document is a formal resolution about the interim financial statement review, it functions as a regulatory disclosure. I will classify it as an Interim Report (IR) because the entire document revolves around the interim financial statement review and approval, which is the core subject matter, even though it is a secondary document (the approval resolution). If the document were shorter and just announced the IR, RPA would apply. Since this is a formal resolution detailing the review outcome, IR is the closest fit for the subject matter being disclosed.
2020-09-30 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.